Litcius/Paper detail

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

Jeffrey Graham, J. Connor Wells, Shaan Dudani, Chun Loo Gan, Frede Donskov, Jae‐Lyun Lee, Christian Kollmannsberger, Luís Meza, Benoit Beuselinck, Aaron R. Hansen, Scott North, Georg A. Bjarnason, Nicolas Sayegh, Ravindran Kanesvaran, Lori Wood, Sébastien J. Hotte, Rana R. McKay, Toni K. Choueiri, Daniel Y.C. Heng

2022European Journal of Cancer35 citationsDOI

Topics & Concepts

Renal cell carcinomaMedicineOncologyImmune checkpointInternal medicineNivolumabCancer researchImmunotherapyCancerRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy | Litcius